X-Linked Protoporphyria clinical trials at UCSF

1 in progress, 0 open to eligible people

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sorry, not currently recruiting here
To evaluate the long-term safety and tolerability of oral dersimelagon.
San Francisco, California and other locations

Last updated: August 23, 2021